Skip to main content
Krakchemia S.A. logo

Krakchemia S.A. — Investor Relations & Filings

Ticker · KCH ISIN · PLKRKCH00019 LEI · 259400QGYEAGRYCQ5Y56 WAR Wholesale and retail trade
Open in API
Filings indexed 587 across all filing types
Latest filing 2019-04-15 Capital/Financing Update
Country PL Poland
Listing WAR KCH

About Krakchemia S.A.

https://www.krakchemia.pl/en

Krakchemia S.A. is a distributor specializing in the wholesale trade of chemical products and plastics. The company's core offerings include a wide range of plastic raw materials, such as granules, and various types of packaging films. Its product portfolio also encompasses laboratory chemicals, reagents, and other chemical raw materials for industrial and commercial applications. The company provides value-added services, including the slitting and rewinding of films, utilizing modern machinery for materials intended for food contact.

Recent filings

Filing Released Lang Actions
ZAWARCIE ANEKSU DO UMOWY KREDYTOWEJ I ANEKSU DO UMOWY O LIMIT NA GWARANCJE Z ALIOR BANK SA - Content (PL)
Capital/Financing Update Classification · 99% confidence The document is a short regulatory filing (1041 characters) from a Polish company (Krakchemia S.A.) informing about amendments (aneks) to existing credit and guarantee agreements with Alior Bank S.A. It details the extension of credit lines and guarantee limits. This type of announcement, concerning financing activities and capital structure adjustments (even if it's just extending existing debt facilities), fits best under 'Capital/Financing Update' (CAP). It is not a full report (10-K, IR), an earnings release (ER), or a management discussion (MDA). Given the specific nature of updating credit terms, CAP is more precise than the general fallback RNS.
2019-04-15 Polish
WSTĘPNE WYNIKI FINANSOWE ZA 2018 ROK - Content (PL)
Earnings Release Classification · 95% confidence The document provides preliminary, unaudited consolidated financial data (net sales, operating loss, net loss) for the period ending December 31, 2018. It explicitly states these figures are estimates and that the final results will be presented in the annual report (raport roczny) due on April 30, 2019. The content focuses on key financial highlights for a period shorter than a full year's final audited report, but it is more detailed than a simple press release. Since it contains comprehensive preliminary period results (not just highlights) and discusses impairment testing (MSR 36), it fits the definition of a comprehensive financial report for a period shorter than a year, even though the period ends on Dec 31st (which is often the year-end, but here it is presented as preliminary data preceding the final 10-K/Annual Report). Given the context of providing detailed preliminary period results, the most appropriate classification is Interim / Quarterly Report (IR), as it serves as the comprehensive pre-audit disclosure for the period, even if the period is the full fiscal year, because the document itself is explicitly preliminary and not the final audited report (10-K). However, since the period covered is the full fiscal year (Jan 1 to Dec 31, 2018), and it explicitly mentions the final results will be in the 'raport roczny' (annual report), this document functions as the preliminary release of the annual results. In many jurisdictions, preliminary full-year results released before the final audited 10-K are often categorized similarly to comprehensive interim reports or as a specific type of Earnings Release (ER) if they only contain key figures. Since this document contains detailed calculations regarding goodwill impairment and specific loss figures, it goes beyond a simple ER. Given the options, and recognizing it is a comprehensive pre-audit disclosure for a reporting period, 'IR' (Interim / Quarterly Report) is often used for comprehensive pre-audit disclosures, even if the period is the full year, when the final 10-K is pending. Alternatively, because it is the preliminary full-year result, it is very close to an ER, but more detailed. Given the detail on impairment testing and specific loss figures, it is more substantial than a typical ER. I will classify it as IR based on the comprehensive nature of the preliminary data release preceding the final audited report. FY 2018
2019-03-29 Polish
ZAWARCIE ANEKSU DO UMOWY KREDYTOWEJ Z ALIOR BANK SA - Content (PL)
Capital/Financing Update Classification · 99% confidence The document is a short announcement (637 characters) from the Management Board of Krakchemia S.A. regarding the signing of an addendum (aneks) to a credit agreement (umowa kredytowa) with Alior Bank S.A., extending the credit line. This action directly relates to the company's financing activities and capital structure. Based on the definitions, this fits best under 'Capital/Financing Update' (CAP). It is not a full report, an earnings release, or a management change announcement.
2019-03-26 Polish
POWOŁANIE ZARZĄDU KRAKCHEMIA S.A. NA NOWĄ KADENCJĘ - Content (PL)
Board/Management Information Classification · 99% confidence The document text, written in Polish, explicitly states that the Supervisory Board ('Rada Nadzorcza') of KRAKCHEMIA S.A. passed a resolution regarding the selection of the Management Board ('Zarząd Spółki') for a new term. It then names the appointed individuals (Andrzej Zdebski as CEO and Łukasz Adach as Vice-CEO) and provides detailed biographies for both, including their qualifications and lack of conflicts of interest. This content directly corresponds to the definition of 'Board/Management Information' (MANG), which covers announcements of changes in the company's board of directors or senior management.
2019-03-21 Polish
PODPISANIE ANEKSU DO UMOWY KREDYTOWEJ Z MBANK S.A. - Content (PL)
Capital/Financing Update Classification · 99% confidence The document text, written in Polish, discusses the signing of an annex (amendment) to a current account credit agreement ('aneks do umowy o kredyt w rachunku bieżącym'). It details the extension of the credit utilization period and the change in the repayment deadline for a specific amount (4,750 thousand PLN). This action directly relates to the company's financing activities and capital structure changes, specifically concerning debt instruments. This aligns best with the 'Capital/Financing Update' category.
2019-03-13 Polish
ZAWARCIE ANEKSU DO UMOWY KREDYTOWEJ Z ALIOR BANK SA - Content (PL)
Capital/Financing Update Classification · 99% confidence The document is a short announcement (689 characters) from the Management Board of Krakchemia S.A. regarding the signing of an addendum (aneks) to a credit agreement with Alior Bank S.A. This addendum extends the credit period. This action directly relates to the company's financing activities and capital structure. Based on the definitions, 'Capital/Financing Update' (CAP) is the most appropriate category for updates on financing agreements. It is not a general regulatory filing (RNS) because it fits a specific financial category, nor is it an earnings release or a report announcement (RPA) as it details a specific transaction.
2019-02-28 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.